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GROUP BEHAVIORAL THERAPY FOR ADOLESCENTS
WITH TIC-RELATED AND NON-TIC–RELATED
OBSESSIVE–COMPULSIVE DISORDER
Joseph A. Himle, Ph.D.,n Daniel J. Fischer, M.S.W., Michelle L. Van Etten, Ph.D., Amy S. Janeck, Ph.D.,
and Gregory L. Hanna, M.D.
Prior research supports the distinction between tic-related and non-tic–related
obsessive–compulsive disorder (OCD) based on phenomenologic, etiologic, and
neurobehavioral data. The present study examines whether response to
psychosocial treatment differs in adolescents, depending on the presence of
comorbid tics. Nineteen adolescents, 12–17 years of age, participated in 7-week,
uncontrolled trial of group cognitive–behavioral treatment (CBT) for OCD.
Eight of the patients had tic-related and eleven had non-tic–related OCD. The
group CBT program included psycho-education, exposure and response
prevention, cognitive strategies, and family involvement. Significant improve-
ment was observed for all subjects on the Yale-Brown Obsessive Compulsive
Scale ratings of obsessions, compulsions, and total OCD symptoms. Outcomes
were similar for subjects with tic-related and non-tic–related OCD. These
preliminary results suggest that the presence of comorbid tic disorders may not
attenuate response to behavioral group treatment among adolescents.
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INTRODUCTION
Obsessive–compulsive disorder (OCD) has been
found to co-occur with tic disorders. Nearly 60% of
children and adolescents with OCD will develop tics at
some point in their lives [Leonard et al., 1992].
Leckman and colleagues [Leckman et al., 2000] coined
the terms tic-related and non-tic–related OCD to refer
to what is believed to be a meaningful distinction
between these subtypes of OCD. This distinction is
supported by differences in sex ratio, with tic-related
OCD over-represented among males [George et al.,
1993; Leckman et al., 1995; Leonard et al., 1992]. The
distinction between tic-related and non-tic–related
OCD is also supported by data indicating an earlier
age of onset for tic-related-OCD [de Groot et al.,
1994; Leonard et al., 1992]. Additionally, an increased
rate of OCD has been found among family members of
patients with Tourette’s syndrome, regardless of
whether the proband had co-morbid OCD [Comings
and Comings, 1987; Eapenet al., 1993; Pauls et al.,
1986, 1991]. Neurobiologic dif ferences have also been
observed between these subtypes [Hanna et al., 1991].
Examining OCD symptom profiles is another
method that has been used to investigate differences
between tic-related and non-tic–related OCD. Rituals
related to touching, tapping, rubbing, blinking, or
staring appear to be more common among OCD
patients with comorbid tics [Holzer et al., 1994;
Leckman et al., 1995] or Tourette’s syndrome [George
et al., 1993; Leckman et al., 1994]. Additionally, several
studies have found a lower prevalence of contamination
obsessions and washing/cleaning compulsions among
patients with tic-related-OCD [Baer, 1994; de Groot
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et al., 1995; George et al., 1993; Holzer et al., 1994;
Leckman et al., 1995].
A final method, useful in making distinctions
between tic-related and non-tic–related OCD, is
response to treatment. McDougle and colleagues
[1994] found a selective response to fluvoxamine
augmented with haloperidol among patients with tic-
related OCD. Individuals with tic-related OCD
experienced significant improvement when haloperidol
was added to fluvoxamine, whereas haloperidol aug-
mentation did not result in improvement among
patients with non-tic–related OCD. However, a recent
study of patients with treatment resistant OCD, who
were given risperidone augmentation of various ser-
otonin reuptake-inhibiting medications, found signifi-
cant improvement among both patients with tic-related
and non-tic–related OCD [McDougle et al., 2000].
The conflicting results of these studies make it difficult
to draw firm conclusions about dif ferential pharmaco-
therapy response between tic-related and non-tic–
related OCD. No studies exist that test the differential
effect of cognitive–behavioral therapy (CBT), the other
primary treatment for OCD [Franklin et al., 1998;
March et al., 1994; Piacentini, et al., 2002; Rachman
and Hodgson, 1980], for tic-related vs. non-tic–related
OCD. At least two anecdotal reports suggest tic-related
OCD may not respond as well to CBTas does non-tic–
related OCD [King et al., 1998; Leckman et al., 2000].
This observation may be in part due to symptom
profile dif ferences between tic-related and non-tic–
related OCD, as noted above. Contamination/washing
and doubting/checking symptoms are less common in
tic-related OCD but have been shown to respond
better to CBT [Buchanan et al., 1996; Drummond,
1993]. Clinical impressions would also suggest that
rituals related to touching, tapping, rubbing, staring,
and blinking, which are more prevalent in tic-related
OCD, may be more difficult to treat with exposure and
response prevention. Further research is warranted
to investigate whether tic-related OCD responds
dif ferently than non-tic–related OCD to medication
and/or CBT.
We present an uncontrolled clinical trial of group
cognitive–behavioral therapy for adolescents with
either tic-related or non-tic–related OCD.
SUBJECTS AND METHODS
Subjects were 19 adolescent patients with the
diagnosis of OCD who were recruited through the
child and adolescent division of the University of
Michigan, Department of Psychiatry, and completed a
7-week course of group CBT (n¼1 dropout). Partici-
pants were drawn from the larger clinic sample (n¼52),
and represent those study-eligible adolescents who
expressed an interest in participating in group CBT,
and were available during the scheduled group time.
Nine of the patients (five with tic-related OCD and
four with non-tic–related OCD) received an extensive
diagnostic evaluation as participants in a family study
of OCD. They were interviewed with the Schedule for
Affective Disorders and Schizophrenia for School-Age
Children–Epidemiologic Version [KSADS-E; Or-
vaschel, 1987]. The interview was completed indepen-
dently with a parent of the patient as well as with the
patient. The interview was supplemented with the
sections on OCD and tic disorders from the Schedule
for Tourette and Other Behavioral Syndromes [Pauls
and Hurst, 1991]. The remaining 10 patients (three
with tic-related OCD and seven with non-tic–related
OCD) received diagnostic evaluations performed by
faculty and staff clinicians (e.g., social workers,
psychologists, and psychiatrists) who were well trained
in the identification and diagnosis of OCD using
DSM-III-R or DSM-IV criteria [American Psychiatric
Association, 1987, 1994]. Tic-related OCD was de-
fined as a current DSM-IV tic disorder diagnosis, and
non-tic–related OCD required a lack of any lifetime
history of tics. Altogether, eight patients had tic-related
OCD and 11 had non-tic–related OCD. Patients with
bipolar disorder, severe major depression, mental
retardation, pervasive developmental disorder, schizo-
phrenia, or other psychotic disorders were excluded
from participating in the group. Of those expressing an
interesting the group treatment, one patient was
excluded due to comorbid pervasive developmental
disorder.
The sample consisted of 11 boys and 8 girls. The
mean age was 14.63 (SD¼1.71) years. All patients were
attending either middle or high school. Mean age of
OCD onset was 11.09 (SD¼3.26) years and duration of
illness was 4.08 (SD¼3.2) years. Cormorbidity for both
groups is presented in Table 1. Depression and other
anxiety disorders were the most common comorbid
disorders. Patterns of comorbidity were similar for
both subtypes. Table 2 presents primary OCD symp-
toms for the tic-related and non-tic–related groups.
Primary symptoms related to contamination/washing
were more common in the non-tic–related subtype,
whereas harm obsessions/compulsions were slightly
more prevalent in the tic-related group. Thirteen











Oppositional-defiant disorder 1 1
Separation anxiety disorder 2 2
Panic disorder 0 1
Social phobia 0 1
Agoraphobia 1 1
Specific phobia 1 1
Generalized anxiety disorder 1 1
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patients were taking psychotropic medication at the
start of the group (six with tic-related OCD and seven
with non-tic–related OCD). Medications included
fluoxetine (five patients), fluvoxamine (three), clomi-
pramine (six), sertraline (one), clonidine (two), methyl-
phenidate (two), dextroamphetamine (one), guanfacine
(two), buproprion (one), and lithium (one). Medication
doses were held constant from 3 weeks prior to the
group through the end of the group. No individual
therapy (cognitive–behavioral or otherwise) was pro-
vided during the group. Five of the patients (two tic-
related and three non-tic–related) participating in the
group had previously been non-responsive to indivi-
dual CBT. All medicated patients were either partially
or non-responsive to OCD medication.
GROUP TREATMENT
All patients were given seven weekly, 90-minute,
group CBT sessions conducted over a 2-year period
[see Fischer et al., 1998, for a complete description of
the group therapy format). Each of the four groups was
closed-ended and included four to six patients (thera-
pist DJF). Patients with and without tics were treated
together in the same group. Treatment was designed to
address OCD symptoms and not tics. The treatment
program focused upon exposure and response preven-
tion conducted in-session and through homework
assignments, and also included instruction in a
cognitive framework for externalizing OCD as an
enemy to battle (following March et al., 1994), and
education about the nature of OCD. Efforts were made
to facilitate group cohesiveness and mutual reinforce-
ment for treatment compliance, and to instruct members
in the use of coping self-statements (e.g., ‘‘It’s not me, it’s
my OCD’’). Each session included an educational topic
in addition to CBT. The six educational topics included
the nature of OCD, principles of behavioral therapy,
causes of OCD, family life and OCD, specialized
techniques for making CBT more effective, and life-
styles and OCD. Additionally, an optional eighth session
for patients and their parents was offered. During this
session, parents were educated about the nature and
treatment of OCD and the group leader facilitated a
discussion of OCD related family problems.
MEASURES
The Children’s Yale-Brown Obsessive–Compulsive
Scale [CY-BOCS; Goodman et al., 1989a,b; Scahill
et al., 1997] was used to rate the severity of obsessive–
compulsive symptoms at baseline and post-treatment.
The CY-BOCS is a clinician rated scale that measures
the severity of ten items, ranging from 0 (none) to 4
(extreme). (The 10 items are divided into two subscales:
obsessions and compulsions.) CY-BOCS severity is
rated as 0–7 sub-clinical, 8–15 mild, 16–23 moderate,
24–31 severe, and 32–40 extreme. The CY-BOCS has
good face and content validity, inter-rater reliability,
and a high degree of internal consistency [Scahill, et al.,
1997]. Baseline and post-treatment CY-BOCS ratings
were completed by trained clinicians blinded to pre
versus post group status.
RESULTS
The tic-related and non-tic–related OCD groups did
not significantly dif fer in sex ratio (25% female tic-
related; 55% female non-tic–related; w2¼1.659; df¼1;
P¼.352), mean age (tic-related Ms¼14.25; SD¼1.34;
non-tic–related Ms¼14.91; SD¼1.92; t¼.824; df¼17;
P¼.422), or initial CY-BOCS score (tic-related
Ms¼24.5; SD¼7.61; non-tic–related Ms¼20.18;
SD¼8.42; t¼1.148; df¼17; P¼.267).
All 19 patients showed improvement in CY-BOCS
scores from the beginning to the end of the group (see
Fig. 1). Paired Student’s t-tests for all subjects pooled
together revealed significant improvement from the
baseline (Ms¼22.00; SD¼8.17) to post treatment
(Ms¼15.32; SD¼6.62; t¼6.78; df¼18; Po.0001). Sig-
nificant improvement in CY-BOCS obsession sub-
scores were also observed from baseline (Ms¼10.61;
SD¼4.12) to post-treatment (Ms¼8.11; SD¼3.27;
t¼4.06; df¼18; P¼.001). Finally, CY-BOCS compulsion
sub-scores improved from the beginning (Ms¼11.39;
SD¼4.26) to the end of the group Ms¼7.21 (SD¼3.54;
t¼9.08; df¼18; Po.0001). Outcome was not signifi-
cantly affected by medication status for the overall
sample (df¼17; t¼.291; P¼.774) nor for the tic-related







Harming Others/Repeating 2 1
Harming Others/Checking 1 1
Harm Coming to Others/Checking 2 1

























Figure 1. Pre-post treatment scores for individual subjects with
tic-related vs. non-tic–related OCD.
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(df¼6; t¼1.04; P¼.84) nor non-tic–related subtypes
(df¼9; to0.001; P¼.99).
Repeated measures analysis of variance was per-
formed to compare differences in treatment response
between tic-related and non-tic–related OCD from
baseline to post-treatment. No significant tic group by
time interaction for total CY-BOCS scores was
observed from baseline to post-treatment between the
tic-related and non-tic–related groups (F¼1.32; df¼1,
17; P¼.27). Similarly, dif ferences were not statistically
significant across tic groups from baseline to post-
treatment for obsession scores (F¼0.26; df¼1, 17;
P¼.62) or compulsion scores (F¼3.44; df¼1, 17;
P¼.08).
DISCUSSION
Although clearly preliminary, the findings of this
uncontrolled trial of group CBT for adolescent
patients with tic-related and non-tic–related OCD
suggest that the distinctions between these groups
may not extend to dif ferential response to CBT
treatment. Similar CBT outcomes were obtained
despite the expected increased prevalence of contam-
ination/washing symptoms among the non-tic–related
group. Symptom profiles between tic-related and non-
tic–related OCD are likely to dif fer, but those
dif ferences may not influence CBT outcomes. Addi-
tionally, the similar comorbidity patterns observed
between the tic-related and non-tic–related groups
suggest that CBToutcomes were not unduly altered by
these comorbid conditions.
The finding of similar CBT outcomes between tic-
related and non-tic–related OCD is especially note-
worthy, given conflicting results regarding response to
pharmacotherapy found among patients with tic-
related and non-tic–related OCD [McDougle et al.,
1994, 2000]. The results of this study also run counter
to clinical impressions that tic-related OCD does not
respond as well to CBT [King et al., 1998; Leckman
et al., 2000].
If confirmed in future research with a larger sample
size, the comparable response to behavioral treatment
between tic-related and non-tic–related OCD would be
somewhat surprising in light of the distinctive
phenomenological (early onset) [de Groot et al.,
1995; Leonard et al., 1992], neurobiological [Hanna
et al., 1991], and family data [Comings and Comings,
1987], suggesting that these OCD subtypes differ in
certain aspects of their pathophysiology. It has been
suggested that tic-related OCD is complicated by a
dopaminergic dysfunction that compromises the re-
sponse to monotherapy with serotonergic antidepres-
sants [McDougle et al., 1994]. Despite these
dif ferences, the results of this study suggest that
comorbid tic disorders may not attenuate the response
to group CBT among adolescents with OCD.
Methodological limitations of this study suggest that
these results should be interpreted with some caution.
The small sample size and the resulting limited
statistical power increase the risk of type-II error.
However, it is important to note that the amount of
improvement from baseline to post-treatment was
actually greater in the tic-related group compared to
the non-tic–related group, although this difference was
not significant. Sex ratio differences between the two
groups may have influenced treatment outcome but it
is important to note that the higher prevalence of males
in the tic-related group is typical of this subtype [Geller
et al., 1998]. Additionally, it is possible that the
comparable treatment response observed in both the
tic-related and non-tic–related groups was in part due
to a floor effect created by inclusion of two subjects
with particularly low baseline CY-BOCS scores in the
non-tic–related group (total CY-BOCS o 10). How-
ever, excluding these subjects from analyses did not
alter the finding of non-significance in treatment
response between the two subgroups under study.
Second, this study was an uncontrolled clinical trial,
making it possible that a portion of the treatment effect
may be due to non-specific factors. However, there is
no reason to anticipate that the tic-related and non-tic–
related subtypes would have responded differentially to
placebo effects, thus limiting the likelihood that the
absence of a control group posed a notable confound in
the current investigation. Third, the study lacks a
measure of tic severity, which may influence treatment
outcome for subjects with tic-related-OCD, although
it is important to note that the sample size in the
present study would not have had sufficient statistical
power to detect subgroup differences even if these
measures were available. Finally, assessment of changes
in tic severity over the course of the group and use of
structured diagnostic interviews for all subjects would
have enhanced the methodological rigor of this study.
Methodological strengths of the study, however,
include the use of a manualized treatment program,
psychometrically sound outcome measures, and blind
independent ratings of progress.
The discussed shortcomings notwithstanding, it
appears in this small sample of adolescents that group
CBT is effective for both tic-related and non-tic–related
OCD. The present results stand as the only data that
examine the differential response to CBT among
subjects with these OCD subtypes. These preliminary
results stand in contrast to the clinical impression that
tic-related OCD responds less well to CBT [King et al.,
1998; Leckman et al., 2000]. Further research using a
control group and other methodological improvements
is needed to confirm these findings.
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